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Hyaluronan has recently been introduced as a vehicle hyaluronan and its metabolites, free acetate and water.
Hyaluronan absorption was similarly demonstratedfor topical application of drugs to the skin. We sought
to determine whether hyaluronan acts solely as a without polyethylene glycol, which is usually included
in the topical formulation. [3H]hyaluronan absorptionhydrophilic reservoir on the surface of intact skin or
might partly penetrate it. Drug-free hyaluronan gels was not restricted to its smaller polymers as demon-
strated by the recovery of polymers of (360–400 kDa)were applied to the intact skin of hairless mice and
human forearm in situ, with and without [3H] from both blood and skin. This finding suggests that
its passage through epidermis does not rely on passivehyaluronan. [3H]hyaluronan was shown by autoradio-
graphy to disseminate through all layers of intact skin diffusion but may be facilitated by active transport.
This study establishes that hyaluronan is absorbed fromin mouse and human, reaching the dermis within
30 min of application in mice. Cellular uptake of the surface of the skin and passes rapidly through
epidermis, which may allow associated drugs to be[3H]hyaluronan was observed in the deeper layers of
epidermis, dermis, and in lymphatic endothelium. carried in relatively high concentration at least as
far as the deeper layers of the dermis. Key words:Absorption through skin was confirmed in mice by
chromatographic analysis of blood, urine, and extracts glycosaminoglycans/metabolism/transdermal drug delivery.
J Invest Dermatol 113:740–746, 1999from skin and liver, which identified 3H as intact
T penetrate the epidermis. It adopts a stiffened random-coil molecularconfiguration that occupies a large volume in proportion to itspolymer size (Laurent et al, 1960) and overlaps at a relatively lowconcentration (Laurent, 1970). These properties should furtherhinder its passage, although they promote its ready formation ofhe fate of substances applied to the surface of the skindepends upon their ability to penetrate the stratumcorneum, which consists of hydrophilic cornified cellsembedded in a dense hydrophobic matrix. Bothexperimental evidence and practical experience show
that passage through this layer is facilitated if the substance is viscoelastic gels potentially suitable for surface retention, acting as
a surface reservoir for therapeutic agents.lipophilic or amphiphilic (that is, both hydrophilic and lipophilic);
it will be further influenced by molecular weight, the character of Recent work, however, has revealed several kinds of intramolecu-
lar hydrogen bonds that form along the saccharide chain of HA inany solvent, and the relative solubility in the solvent and the
stratum corneum (Gozzo et al, 1996). Unless sustained moistening the hydrated state. These impart a twist that creates alternating
sequences of eight exposed -CH groups and confers an amphiphilichydrates the skin, hydrophilic substances will penetrate very slowly,
but they can be retained on the surface as a suitably adhesive gel character (Scott, 1989). Contrary to the principles cited above,
other apparently hydrophilic polymers such as insulin (Ogiso et al,for protection of the skin or slow release of an amphiphilic drug.
More recently hyaluronan (HA), a ubiquitous component of the 1996), dextrans (Ogiso et al, 1995), interferon gamma (Short et al,
1995), and other glycosaminoglycans (Stuttgen et al, 1990) haveextracellular matrix, has been successfully used for the application
of certain drugs to the skin where it is thought to act as a sustained also been shown to penetrate skin. In the light of Scott’s findings,
we were therefore prompted to determine whether HA would dorelease and localized delivery vehicle (Moore and Willoughby,
1995). HA is a linear polymer of N-acetyl glucosamine and likewise despite its apparent impediments. Such an outcome would
be pertinent not only to its therapeutic usage but also to itsglucuronic acid in alternating sequence and its carboxyl groups are
largely ionized at the pH prevailing on the skin surface. It is movements and turnover deeper in the skin, and to the use of
other polymers that might be deleterious if similarly absorbed.therefore strongly hydrophilic, and in agreement with observations
in the Franz chamber (Brown et al, 1995), seems unlikely to
MATERIALS AND METHODS
Animals SKh/1 hairless mice were obtained from Animal Resource
Center (Perth, WA, Australia). Mice ranged in age from 3 to 6 mo and
were of both sexes.Manuscript received March 23, 1999; revised July 6, 1999; accepted for
publication July 15, 1999.
Correspondence: Dr. Robert Fraser, Department of Molecular Biology Human subject The person was a healthy male without skin disease.
and Biochemistry, Monash University, Wellington Road, Clayton, Mel-
bourne, Victoria 3168, Australia. Preparation of hyaluronan gels Two batches of HA labeled with 3H
in its acetyl groups were prepared by biosynthesis, purified, and reducedAbbreviations: CPC, cetylpyridinium chloride; HA, hyaluronan.
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Table I. Formulations of gels used in the mouse and human experiments
Experiment Components per gram of gel
Polyethylene Benzyl Non-radioactive [3H] HA
glycol (mg) alcohol (%vol/vol) HAa (mg)
(mg) Mr Specific activity
(dpm/mg total HA)
Mouse study
Series 1 (repeated applications) n 5 16 143 0.7 17.9 0.5 2.5 3 105 6.4 3 106
Series 2 (single application)
n 5 10 108 0.5 13.4 3.3 4.0 3 105 31.6 3 106
n 5 10 – 0.5 13.4 3.3 4.0 3 105 31.6 3 106
Series 2 (single application) n 5 25 108 0.5 12.5 1 4.0 3 105 23.3 3 106
Human study – 0.5 13.4 3.3 4.0 3 105 31.6 3 106
aMr 4 3 10
5 Daltons.
by sonication (Fraser et al, 1988) to a modal Mr of 2.5 3 105 and 4.0 3 105, Activity in tissue samples was determined after adding 10 or 15 ml of
Wallac Hisafe II scintillant. Definitive activity was measured for 20 minrespectively. These were lyophilized, redissolved in pyrogen-free distilled
water, and incorporated in the therapeutic gels by repeated vortex mixing after decay of photo- and chemiluminescence was verified by stabilization
of repeated preliminary counting.and centrifugation at 500 3 gav to ensure thorough mixing. Radiochemical
purity was . 99.5% as determined by digestion with Streptomyces hyaluroni-
dase (refer to Methods of Analysis). Two series of mouse and one series of Histology and autoradiography Fixed skin was dehydrated stepwise
to 100% ethanol and embedded in paraffin. Sections of 2–4 µm werehuman experiments were conducted (refer to Table I for components of
experimental gels). placed in pairs on slides, dewaxed, and rehydrated. One of each pair was
immersed in Streptomyces or testicular hyaluronidase in 0.1 M phosphate
buffer, pH 6.8, with protease inhibitors as previously described, and thePreparation of samples for 3H analysis
Liver Each was excised, weighed, and frozen immediately after death. For other in the same solution without enzyme. The slides were held in a
humidified chamber for 4 h at 37°C, washed, drained, dipped in dilutedmeasurement of total radioactivity per g wet wt, 100–300 mg was solubilized
in 3 ml of Wallac Optisolve (LKB, Melbourne, Victoria, Australia) for Ilford K5 autoradiographic emulsion (Ilford Australia, Melbourne, Australia)
at 40°C, and drained again. After 2 or 3 wk in airtight chambers at 22°C,24 h at 22°C. The remainder was dispersed in phosphate-saline buffer, 1:1
wt/vol with sodium azide, 0.02% wt/vol, for 1 min in a Polytron PCU the emulsions were developed in Kodak D19 and fixed in Hypam Rapid
Fixer (Ilford). The sections were then washed and lightly stained withhomogenizer (Kinematica, Steinhofhalde, Switzerland), held at 4°C for
3 d, then frozen and thawed three times. The supernatant was recovered hematoxylin.
after centrifugation at 113,000 3 gav for 2 h at 4°C.
Experimental
Mice To estimate amounts applied, the gel was weighed on a tared smoothSkin The washed or swabbed tissue (mouse, 219–293 mg, human, 3.4 mg;
see later) was solubilized in 2 ml of Wallac Optisolve (LKB) for 15 h at latex fingerstall. In mice, about 50 mg (range 44.7–63.1 mg) was gently
rubbed on a marked area of 5–6 cm2 on the dorsum of the trunk.22°C. For identification of [3H] molecules in the skin, a section of swabbed
skin was digested by incubating with 400 U of collagenase type IV Fingerstalls were then thoroughly soaked for 48 h in 2 ml of distilled water
to measure the residue as 3H.(Worthington Biochemicals, NJ) in 50 mM phosphate/NaCl buffer con-
taining 1 mM calcium chloride, pH 7.25, for 12 h at 37°C. The digest
was centrifuged at 113,000 3 gav for 30 min; analysis was performed on Series 1 (repeated HA applications) Mice were allotted to two groups of
four. In each, four were treated with radioactive gel and four withthe supernatant.
nonradioactive gel. At 12 hourly intervals, one group received three
applications of gel and the other 12. The animals were killed for removalBlood Serum was prepared from blood collected immediately after death;
50 µl aliquots were decolorized with 100 µl of H2O2 30% vol/vol, for of tissues 12–16 h after the last application.
measurement of 3H content.
Series 2 (single HA applications) Mice were treated with a single application
of [3H]HA gel (range: 51.3–70.3 mg), held individually, with free accessUrine This was centrifuged at 14,000 3 gav for 10 min.
to food and water, in soft nonwettable plastic enclosures and constantly
observed to ensure that they had not licked or rubbed the treated skin.Methods of analysis Chromatography of serum, urine, and tissue
extracts or digests was performed as follows: (i) in Superose 12 (Pharmacia, Mice were killed 0.5, 1, 2, 4, 8, 16, and 24 h after application of the gel.
Two mice were included in each series for histologic comparison ofUppsala, Sweden), column 1 cm 3 30 cm, sample volume 0.5 ml, fractions
0.5 ml, elution rate 24 ml per h; (ii) in Sephacryl S-300 (Pharmacia), untreated skin.
column 1.6 cm 3 70 cm, sample volume 2 ml, fractions 2 ml, elution
rate 14 ml per h; (iii) in Sephacryl S-1000 (Pharmacia), column Removal of skin The treated skin of the mice was excised, weighed, and
pinned on a flat base to its original size. Half was removed for solubilization1.6 cm 3 63 cm, sample volume 2 ml, fraction size 2 ml, elution rate
18 ml per h. A 0.15 M NaCl-phosphate buffer, pH 7.25 (Fraser et al, and further analysis. The rest remained pinned while fixed for 16 h
with 4% formaldehyde (i) in 0.174 M phosphate buffer, pH 7.5, and1981) was used for tissue extraction or sample dilution with the addition
of 0.2% Triton X-100 (New England Nuclear, MA) for chromatography. cetylpyridinium chloride (CPC), 0.5% wt/vol (series 1), or (ii), in 0.06 M
phosphate, pH 7.5, and CPC 1.0% wt/vol (series 2). The fixativeHA was identified in macromolecular fractions by repeating chromato-
graphy in Superose 12 to determine the proportion reduced to oligosacchar- was recovered for chromatographic analysis of its 3H content. Before
solubilization, the unfixed skin in series 1 was gently agitated for 30 minide after digestion with Streptomyces hyaluronidase, 10 turbidity reducing
units (TRU) per ml, for 6 h at 37°C. HA was identified in skin three times in 3 ml of saline (0.9%NaCl solution); in series 2 the surface
of the whole specimen was first swabbed with cotton moistened withby pretreating de-waxed paraffin sections with Streptomyces or testicular
hyaluronidases (Calbiochem, CA), 50 TRU per ml dissolved in 0.1 M saline. Initial trials in mice showed that massage of the gel on the skin for
7 min generated small cohesive fragments and left only some 20% of thephosphate buffer, pH 6.8, containing protease inhibitors ovomucoid 250 µg,
soybean trypsin inhibitor and pepstatin each 2 µg, iodoacetic acid 1 mM, 3H content on the skin. Thereafter application was ceased at the first sign
of stickiness, which appeared within 2–5 min.and ethylenediamine tetraacetic acid 1.5 mM.
Estimation of radioactivity A Wallac 1410 counter (Pharmacia) was Human In the human study two applications of 56.3 and 56.4 mg were
made to an area of 1.8 cm2, 6 cm below the antecubital crease and 3 cmused. Column fractions were monitored for [3H] activity by adding 3 ml
of Wallac Hisafe II scintillant (LKB) to 0.5 ml of the column fractions. lateral to the medial border, and again 12 h later, with a nonradioactive
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control applied to the other forearm. Seven hours after the second
application, the human skin was swabbed as previously described. Samples
were then removed from both the treated and control areas with a
diagnostic trephine of 3 mm diameter and adherent subcutaneous fat
removed before fixation. 3H activity removed before fixation was measured
in each case.
RESULTS
HA is applied to skin with high efficiency The fraction of
the gel application transferred to the skin ranged from 52 to 99%
(mean 6 SD: 71.4% 6 11.7, n 5 44) in series 1, and from 70 to
91% (mean 6 SD: 81.4% 6 4.6, n 5 38), in the other mice. In
the human study 85% of the second application was transferred to
the skin.
Movement of HA into the keratin, epidermal and dermal
layers of mouse and human skin
Mouse study Both the stratum corneum and deeper layers of the
epidermis were much thinner in the mouse than the human skin.
Nevertheless comparison in mice with untreated skin showed no
epidermal breach, erythrocyte extravasation or inflammatory cell
infiltration in the dermis. Optimum autoradiographic development
occurred after 3 wk. Thereafter, some fading of latent image was
noted. Background development was very slight in the matched
specimens treated with nonradioactive gels.
Series 1. Twelve to 16 h after the last application positive
development was found mainly in the dermis, from the outermost
layer down to the lymphatic and blood vessels just above the
platysma. Where counterstaining was sufficient to stain the collagen
bundles, the silver grains were clearly confined to the ground
substance between them (Fig 1A). Grains were also aggregated at
points in the keratinous layers of the epidermis but very few in its
cellular layers or hair follicles. These findings indicated failure to
penetrate these areas, more rapid transit through them, or degrada-
tion within these layers. Radioactive content was not significantly
higher after 12 than after three applications (Table I). In an attempt
to capture activity in these sites further observations were therefore
made after a single application of gels prepared with a much higher
specific activity.
Series 2. Positive development was found in the same distribution
within dermis as early as 2 h after a single application and later in
platysma (Fig 1B). Grains were also concentrated within cell
boundaries at three levels: in the basal epidermis, in the dermal
matrix and in the lining cells of the lymphatic sinuses (Fig 1C).
We also found grains developed in the keratinized layer of the skin
and in the rudimentary hair follicles. These were not completely
Figure 1. Penetration of hairless mouse skin by topically appliedremoved by Streptomyces or testicular hyaluronidase (Fig 2A). As hyaluronan. [3H]HA was applied to hairless mouse dorsal skin; 4–8 hthere were no grains at these sites in the matched controls (Fig 2B), (series 2) after application the mice were killed, skin removed, and fixed
this observation could not be attributed to artifact. in 0.06 M phosphate, pH 7.5 containing 1% CPC. Tritium was detected
by autoradiography after a 3 wk exposure to K5 autoradiographic emulsion.
Human study Although the density of grains was less intense The absorption of HA into the skin layers is demonstrated as follows. (A)
overall, there was similar aggregation of grains in the keratinized Appearance of topically applied [3H]HA between collagen bundles. Activity
layer (Fig 3A), epidermis (Fig 3B), and clear penetration of activity is retained mainly in the dermis, where the silver grains are arrayed in a
to the deeper dermis with concentration notably at that level and wavy linear pattern corresponding to interstices between collagen fiber
bundles. Hematoxylin counterstain. Scale bar: 50 µm. (B) The ingestion ofjust beneath the epidermis (Fig 3C). With the exception of
[3H]HA by basal epidermal and dermal cells is demonstrated by silverthat noted in the keratinized layers, positive autoradiographic
grains overlying and concentrated in cells (↓). Hematoxylin counterstain.development was reduced to background levels in all specimens
Scale bar: 50 µm. (C) Appearance of silver grains indicating movement ofby digestion with Streptomyces hyaluronidase.
topically applied [3H]HA into lymphatic vessels where silver grains appear
to be concentrated in lymphatic endothelial cells (A), and in deeper dermalRadioactivity recovered from skin (Table II) The fractions
cells (B). Hematoxylin counterstain. Scale bar: 25 µm.of the applied HA recovered from the surface of the skin at the
end of each study were small from 8 h onward. In series 2, the
quantity of applied HA recovered from within the skin was high as HA, identical in molecular weight to the applied HA (Fig 4),
30 min after application, but at 1–8 h after application there was and as its metabolites of acetate and water. No oligosaccharides were
very little difference in the amount recovered from within the found which confirmed that the collagenase was hyaluronidase-free.
skin, suggesting that HA turnover took approximately 1 h to
equilibrate. Mice receiving one or several applications of HA did Transdermal passage of HA into the mouse bloodstream
(Table III) Chromatography in Superose 12 showed a significantdemonstrate a lower proportion of [3H] radioactivity in the skin
12 and 16 h after application. To confirm that [3H] in the skin was macromolecular content as early as 30 min after gel application,
which was identified as HA by its complete degradation withHA or its metabolites the skin was digested with collagenase. After
collagenase digestion the 3H molecules in the skin were identified Streptomyces hyaluronidase (results not shown). The metabolic end-
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Figure 2. Enzyme-resistant retention of [3H]HA in keratin. Mouse
skin was fixed in 0.06 M phosphate, pH 7.5 containing 1% CPC 1 h after
application of [3H]HA gel. (A) Paraffin sections of the skin were pretreated
with Streptomyces hyaluronidase, 50 TRU per ml dissolved in 0.1 M
phosphate buffer, pH 6.8, containing protease inhibitors ovomucoid 250 µg,
soybean trypsin inhibitor and pepstatin each 2 µg, iodoacetic acid 1 mM,
and ethylenediamine tetraacetic acid 1.5 mM. Enzymic treatment did not
remove the [3H]HA retained in the keratinous layer (↓). Hematoxylin
counterstain. Scale bar: 50 µm. (B) Skin from an untreated mouse was
pretreated in the above phosphate buffer which lacked the enzymes. The
lack of autoradiographic artifact is demonstrated by the background levels
of silver grains. The lack of silver grains in the keratin demonstrates that
the keratin retention of 3H in (A) is not experimental artifact. All specimens
of untreated skin were similarly devoid of silver grains in the keratinized
layer (compare A). Hematoxylin counterstain. Scale bar: 50 µm.
products of acetate and water first appeared in the serum at 2 h
after application, indicating that 1–2 h was required to generate
Figure 3. Absorption of topically applied [3H]HA in human skin.detectable catabolism. The molecular weight profile of HA reco-
Two amounts of [3H]HA gel were applied 12 h apart to adult forearmvered in serum was only slightly lower (modal Mr of 3.6 3 10
5 Da, skin in situ. The skin was removed by punch biopsy 7 h after the last
Fig 4B) than that of HA applied to skin, demonstrating that passage application. The skin was fixed in 0.06 M phosphate, pH 7.5, containing
of HA through the skin was not restricted to its smaller polymers. 1% CPC before paraffin sections were made. Tritium was detected by
Furthermore, in contrast to sheep (Fraser et al, 1988), there had autoradiography after a 3 wk exposure to K5 autoradiographic emulsion.
(A) The HA was retained to a lesser extent in the human keratin, butbeen no degradation or selective absorption of the larger polymers
silver grains were still observed (↓). (B) The movement of HA into andin their passage through the lymphatic system or in the bloodstream.
through the cellular layer is represented by the silver granules (↓). (C) A
Kinetics of HA skin absorption as identified by HA and its high concentration of HA was also observed in the deeper dermis (↓).
Hematoxylin counterstain. Scale bar: 25 µm.metabolites in liver and urine
Liver There was negligible difference between activity in solubilized
whole liver and aqueous extracts (extraction efficiency, mean
97.2%) as in other species (Fraser et al, 1981). Recovery from the 0.0008% to 6.065 (mean 6 SD: 0.49% 6 2.31) of the applied
dose. In Superose 12 chromatography, labeled HA and its metabol-extracts is shown in Table IV. From 4 to 8 h after application,
increased amounts of activity were found, but mainly as the ites, acetate and water, were identified in varying amounts as early
as 50 min after application. Analysis in Sephacryl S-300 showedmetabolites of the labeled acetyl group of HA. As in serum,
relatively little was found as intact HA after 4 h, but there was HA as small polymers and oligosaccharides, with fractions of 16–
20 kDa, 2 kDa, and 0.7 kDa. No significant activity was detectedclear evidence that HA had been absorbed and its metabolic
degradation had begun within 1–2 h after application to the skin. in any of the human urine samples.
Optimization of CPC content in skin fixative In series 1Urine Seventeen specimens were obtained 0.73–8 h after applica-
tion of HA. The percentage of [3H] in the urine ranged from after tissues were fixed with formalin in 0.174 M phosphate with
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Table II. Distribution of radioactivity retained in and on the skin after application of [3H]HA formulation to the surface
of the skina
No. of Time after last [3H] HA appliedf [3H] HA remaining on 3H recovered in skinb
applications application (h) (µg HA per g skin) surface of sking
(i) as polymeric HA (ii) as HA metabolites(µg HA per g skin)
µg HA per g skin % of 3Hc [3H]Acetated [3H]Watere
Series 1
3 12 1352.3 6 72.8 17.4 6 1.7 0.04 6 0.02 1.0 6 1.0 3.0 6 2.1 96.0 6 4.8
12 16 1081.3 6 42.1 31.4 6 1.2 0 0 2.0 6 0.5 98.0 6 1.1
Series 2
1 0.5 1361.4 6 89.0 121.9 6 13.7 73.9 6 10.9 100 6 0 0 0
1 1 1295.1 6 61.0 86.0 6 12.7 49.6 6 12.6 99.6 6 0.4 0.4 6 0.2 0
1 2 1403.3 6 71.0 43.4 6 9.8 32.9 6 8.8 95.2 6 0.8 2.1 6 0.4 2.7 6 0.6
1 4 1213.1 6 68.4 85.2 6 18.0 42.5 6 12.7 89.0 6 2.9 4.0 6 0.5 7.0 6 0.9
1 8 1751.0 6 112.4 45.3 6 6.0 24.5 6 4.9 77.2 6 1.7 5.0 6 1.1 17.8 6 2.2
1 16 1242.0 6 66.7 2.5 6 1.5 0 0 2.0 6 0.4 98.0 6 0.4
1 24 2558.8 6 81.9 2.0 6 1.3 0 0 6.1 6 2.1 93.9 6 0.3
Human skin
2 7 29,606 6 0 5462.1 6 0 29.6 6 0h NA NA NA
aFigures represent mean 6 SD, where n 5 4 or 5.
bPercentage was determined by separation in a Superose 12 size exclusion gel.
cUndegraded HA polymer eluted at Kav 0 (Vo).
dAcetate eluted at Kav 0.9.
eWater eluted at Kav 1 (Vt).
fRetained on skin immediately after last application.
gImmediately before removal of skin specimen.
hExpressed as µg HA/g skin, but not discriminated as polymer or metabolites and NA refers to ‘‘not analyzed’’.
content raised to 1% for the rest of the study, only [3H]acetate and
3H2O were detected in the fixative.
Absorption of HA from the gel formulations without poly-
ethylene glycol Penetration of the topically applied HA from
gels with and without polyethylene glycol (10 animals per group,
Table II), showed no difference in the kinetics, quantity or
metabolism of the absorbed HA. The human study showed
penetration throughout the dermis without polyethylene glycol
(Fig 3B, C).
DISCUSSION
Despite the strongly hydrophilic properties inherent in the primary
structure of HA, this work clearly shows, by autoradiography and
radiochemical analysis, that HA applied to the surface of the skin
penetrates normal epidermis to accumulate at least briefly in the
dermis before its disposal and degradation via known metabolic
pathways. The rate-limiting steps in metabolic degradation of HA
in vivo occur mainly at the level of monosaccharides and free acetate
(Fraser et al, 1988, 1989), which should be removed in the aqueous
and ethanolic phases of tissue preparation leaving only labeled
HA. This was confirmed by the reduction of autoradiographic
development to background levels after treatment with Streptomyces
hyaluronidase, which degrades no other glycosaminoglycan. As
noted in the Results section, the development of grains within the
stratum corneum did not appear to be an artifact. As it resisted
both Streptomyces and testicular enzymes, which are, respectively,
exoglycosidases and endoglycosidases, this observation suggests an
unexpectedly close association of HA with some component ofFigure 4. Recovery of high molecular weight [3H]HA in skin and
this layer which is sufficient to hinder access by the enzymes’ activebloodstream of the mouse. Samples were diluted in 0.15 M phosphate/
site, temporarily concentrating the HA at this level.saline/0.2% Teric X10 elution buffer and applied to a Sephacryl S-1000
Passage of HA through skin in mice was confirmed by thegel. Radioactivity was measured in 2 ml fractions after adding 1 ml of
recovery of labeled HA and the products of its metabolic degradationeach fraction to 6 ml of HiSafe II scintillant. (A) Radioactive gel before
application to the mice (series 2). (B) Serum from 0.5 h mouse. (C) in skin, blood, liver, and urine. The failure to find metabolites in
Collagenase digest of skin from 1 h mouse. Note that the very small human urine is explicable by the much greater volume of body
content of HA metabolite in this sample was detectable only in Superose water relative to the applied amount of isotope, and the consequent
12 (refer Table II). dilution of any H2O generated.
The Mr of the first batch of [
3H]HA was lower than that of the
unlabeled HA content, due to an unexpected response to sonication0.5% CPC, the fixative contained a 4 kDa fraction identified by
enzymic digestion as HA, in addition to [3H]acetate and 3H2O. (see Materials and Methods). Nevertheless, the difference between
250 kDa and 400 kDa makes little difference to the Stokes radiusWhen formalin was buffered in 0.06 M phosphate and its CPC
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Table III. Time sequence in appearance of hyaluronan and its metabolites in the mouse bloodstream
HA metabolitesb
Time after last application (h) % of the total applied [3H] Undegraded polymeric Acetated (%) Watere (%)
recovered in seruma [3H]HAc (%)
0.5 0.36 6 0.02 100 0 0
1 0.02 6 0.04 100 0 0
2 0.40 6 0.06 Range: 20–99; Mean: 69 Range: 1–6; Mean: 4 Range: 0–74; Mean: 27
4 0.96 6 0.37 Range: 4–95; Mean: 51 Range: 0–7; Mean: 2 Range: 0–95; Mean: 47
8 4.46 6 1.09 Range: 0–9; Mean: 3 Range: 0–4; Mean: 1 Range: 90–100; Mean: 96
16 4.82 6 0.59 0 Range: 0–5; Mean: 3 Range: 95–100; Mean: 97
24 3.24 6 0.42 0 0 100
aThe d.p.m. appearing in the mouse serum was converted to the percentage of the applied [3H]HA dose by:
mouse weight(g) 3 0.075 (blood volume) 3 0.59(serum volume of mouse) 3 [3H]d.p.m./ml serum 3 100
[3H] d.p.m. transferred to skin
Figures represent mean 6 SD. n 5 4 or 5.
bPercentage of HA metabolites was determined by separation in a Superose 12 size exclusion gel
cUndegraded HA polymers eluted at Kav 0 (Vo)
dAcetate eluted at Kav 0.9
eWater eluted at Kav 1 (Vt)
Table IV. Confirmation of HA passage through mouse skin by identification of HA and its metabolites in liver
HA metabolitesb
Time after last application (h) % of the total applied [3H] Undegraded [3H]HAc (%) Acetated (%) Watere (%)
retained in livera
0.5 0 Analysis not performed Analysis not performed Analysis not performed
1 0.01 6 0.007 Range: 95–98; mean: 97 Range: 1–5; mean: 2 Range: 0–1; mean: 1
2 0.12 6 0.05 Range: 6–96; mean: 42 Range: 0–17; mean: 7 Range: 2–78; mean: 51
4 1.59 6 0.68 Range: 0–6; mean: 3 Range: 1–17; mean: 6 Range: 73–98; mean: 91
8 1.56 6 0.50 Range: 0–2; mean: 1 Range: 0–1; mean: 1 Range: 99–100; mean: 98
16 1.30 6 0.23 0 Range: 0–5; mean: 3 Range: 95–100; mean: 97
24 1.00 6 0.14 0 0 100
aThe d.p.m. appearing in the mouse liver was converted to the percentage of the applied [3H]HA dose by:
liver weight(g) 3 [3H] d.p.m./g liver 3 100
[3H] d.p.m. transferred to skin
Figures represent mean 6 SD. n 5 4 or 5.
bPercentage of HA metabolites was determined by separation in a Superose 12 size exclusion gel.
cUndegraded HA polymer eluted at Kav 0 (Vo)
dAcetate eluted at Kav 0.9
eWater eluted at Kav 1 (Vt)
of HA (see Fraser et al, 1996). In the outcome, the larger labeled corneum and the basal lamina as previously believed (Tammi et al,
1994), but can pass into the dermis.material, corresponding with that in the pharmaceutical preparation,
still penetrated all layers of the skin with unexpected speed. The present findings differ in some respects from studies with
similar labeled HA using human skin in Franz chambers, whereWith the exception of the stratum corneum, the positive autora-
diographic development in all levels of the skin unquestionably very little passed beyond the epidermis during a 6 d interval (Brown
et al, 1995). Its rate of passage beyond the dermis is probably quiterepresented intact HA, for the reasons just given. In series 1, it was
consistently less intense in the deeper layers of the epidermis than different in human and mouse, but it does seem to pass from
epidermis to dermis with similar facility in both. Although cellularin the dermis. This difference was still apparent with the higher
specific activity of the gels and shorter intervals in the subsequent viability is retained in the Franz chamber, exposure for several days
to Sorensen’s buffer would almost certainly impair more complexstudies. The transit of HA through these layers is therefore
remarkably rapid. As there is no inward movement of extracellular cellular functions such as vesicular transport, as it lacks several
essential constituents of extracellular fluid such as glucose, calcium,fluid at this point, its passage must be mediated by extracellular
diffusion, active transport through the cells, or combinations thereof. and magnesium.
Although its dermal distribution was mainly extracellular, cellularThe detection of grains within the basal epidermal cells supports a
role for active transport. An analogy is provided by the facilitated uptake of labeled HA was also seen in this layer. Further steps will
be undertaken to identify these cells, which may be responsible forvesicular transport of nutrients through intestinal mucosa, which is
initiated by carrier proteins oriented on one aspect of the cell the fraction of HA turnover which occurs in situ (Reed et al, 1990).
They might include histiocytes or mast cells as well as fibroblastsmembrane and driven by Na1/K1 pumps (Simionescu et al, 1975).
The amphiphilic properties of HA might also assist its binding to (for review see Tammi et al, 1994). The third group of cells that
clearly absorbed HA was the typically attenuated endothelial cellcell membranes (Scott, 1989). It is now clear that HA normally
generated in the epidermis is not entrapped between stratum of the lymphatic sinuses. These cells might be involved in active
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transport or in metabolism of HA, as similar cells are primarily
responsible for its uptake and catabolism in the hepatic blood We thank Dr George Varigos for taking the human skin biopsies. We gratefully
sinusoids (Eriksson et al, 1983), and its uptake in the lymph nodes acknowledge the support of Hyal Pharmaceutical Corporation, Canada and Hyal
where it is also actively catabolized (Fraser et al, 1989). Pharmaceutical Australia Pty. Ltd. This study was approved by the Animal Ethics
Transport as far as the bloodstream was detected within 1 h of Committee, University of Melbourne and the Human Ethics Committee, Royal
application. There was relatively little evidence of HA catabolism Melbourne Hospital
at that time but at later intervals activity was recovered from serum
largely as metabolites. This sequence suggests that much of the
degradation occurred after the polymers escaped from the skin. REFERENCES
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